All In Biotech

Free tool

FAERS Monitor: Oxytrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021351 or its brand name (Oxytrol, Oxybutynin). Reports on generic versions are filed under their own applications.

Reports

23,120

Serious

13,881

60% of reports

Hospitalization

6,938

Death reported

1,707

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,792
  • fatigue1,543
  • fall1,497
  • nausea1,185
  • diarrhoea1,075
  • urinary tract infection1,053
  • dizziness1,039
  • pain1,012
  • headache949
  • off label use930
  • asthenia903
  • dyspnoea757
  • gait disturbance725
  • constipation707
  • death706

Reports by year received

View as table
YearReports
2004203
2005250
2006188
200773
200880
2009123
2010370
2011595
2012739
2013746
20141,222
20151,549
20161,829
20171,897
20182,032
20192,072
20201,786
20211,489
20221,470
20231,370
20241,014
20251,179
2026843

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,039 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
urinary tract infectionSignal1,0535.65.34,028
fallSignal1,4974.13.93,554
gait disturbanceSignal7253.53.21,269
constipationSignal7073.02.7919
astheniaSignal9032.22.1590
dizziness1,0391.91.8449
fatigue1,5431.81.7573
diarrhoea1,0751.51.4194
pain1,0121.51.4173
headache9491.41.3101
nausea1,1851.41.3118
drug ineffective1,7921.21.287
dyspnoea7571.21.130
off label use9301.00.91
death7060.70.764

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.